PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of molmedLink to Publisher's site
 
Mol Med. 1999 May; 5(5): 261–284.
PMCID: PMC2230419

BHV-1: new molecular approaches to control a common and widespread infection.

Abstract

BACKGROUND: Herpesviruses are widespread viruses, causing severe infections in both humans and animals. Eradication of herpesviruses is extremely difficult because of their ability to establish latent and life-long infections. However, latency is only one tool that has evolved in herpesviruses to successfully infect their hosts; such viruses display a wide (and still incompletely known) panoply of genes and proteins that are able to counteract immune responses of their hosts. Envelope glycoproteins and cytokine inhibitors are two examples of such weapons. All of these factors make it difficult to develop diagnostics and vaccines, unless they are based on molecular techniques. MATERIALS AND METHODS: Animal herpesviruses, because of their striking similarity to human ones, are suitable models to study the molecular biology of herpesviruses and develop strategies aimed at designing neurotropic live vectors for gene therapy as well as engineered attenuated vaccines. RESULTS: BHV-1 is a neurotropic herpesvirus causing infectious rhinotracheitis (IBR) in cattle. It is a major plague in zootechnics and commercial trade, because of its ability to spread through asymptomatic carrier animals, frozen semen, and embryos. Such portals of infections are also important for human herpesviruses, which mainly cause systemic, eye, and genital tract infections, leading even to the development of cancer. CONCLUSIONS: This review covers both the genetics and molecular biology of BHV-1 and its related herpesviruses. Epidemiology and diagnostic approaches to herpesvirus infections are presented. The role of herpesviruses in gene therapy and a broad introduction to classic and engineered vaccines against herpesviruses are also provided. http://link.springer-ny. com/link/service/journals/00020/bibs/5n5p261.html

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (4.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Metzler AE, Matile H, Gassmann U, Engels M, Wyler R. European isolates of bovine herpesvirus 1: a comparison of restriction endonuclease sites, polypeptides, and reactivity with monoclonal antibodies. Arch Virol. 1985;85(1-2):57–69. [PubMed]
  • Misra V, Babiuk LA, Darcel CL. Analysis of bovine herpes virus-type 1 isolates by restriction endonuclease fingerprinting. Arch Virol. 1983;76(4):341–354. [PubMed]
  • Engels M, Steck F, Wyler R. Comparison of the genomes of infectious bovine rhinotracheitis and infectious pustular vulvovaginitis virus strains by restriction endonuclease analysis. Arch Virol. 1981;67(2):169–174. [PubMed]
  • Whetstone CA, Seal BS, Miller JM. Variability occurs in the inverted repeat region of genomic DNA from bovine herpesvirus 1 respiratory, genital and bovine herpesvirus 5 encephalitic isolates. Vet Microbiol. 1993 Dec;38(1-2):181–189. [PubMed]
  • Seal BS, Whetstone CA. Immediate-early gene expression and gene mapping comparisons among isolates of bovine herpesvirus 1 and 5. Vet Microbiol. 1994 Feb;38(4):369–384. [PubMed]
  • Bratanich AC, Sardi SI, Smitsaart EN, Schudel AA. Comparative studies of BHV-1 variants by in vivo--in vitro tests. Zentralbl Veterinarmed B. 1991 Feb;38(1):41–48. [PubMed]
  • Mayfield JE, Good PJ, VanOort HJ, Campbell AR, Reed DE. Cloning and cleavage site mapping of DNA from bovine herpesvirus 1 (Cooper strain). J Virol. 1983 Jul;47(1):259–264. [PMC free article] [PubMed]
  • Castrucci G, Frigeri F, Ranucci S, Ferrari M, Cilli V, Pedini B, Nettleton P, Caleffi F, Aldrovandi V, Herring AJ. Comparative studies of strains of infectious bovine rhinotracheitis virus isolated from latently infected calves. Comp Immunol Microbiol Infect Dis. 1984;7(1):1–10. [PubMed]
  • Engels M, Ackermann M. Pathogenesis of ruminant herpesvirus infections. Vet Microbiol. 1996 Nov;53(1-2):3–15. [PubMed]
  • Yates WD. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can J Comp Med. 1982 Jul;46(3):225–263. [PMC free article] [PubMed]
  • van Oirschot JT. Bovine herpesvirus 1 in semen of bulls and the risk of transmission: a brief review. Vet Q. 1995 Mar;17(1):29–33. [PubMed]
  • Parsonson IM, Snowdon WA. The effect of natural and artificial breeding using bulls infected with, or semen contaminated with, infectious bovine rhinotracheitis virus. Aust Vet J. 1975 Aug;51(8):365–369. [PubMed]
  • Bielanski A, Loewen KG, Hare WC. Inactivation of bovine herpesvirus-1 (BHV-I) from in vitro infected bovine semen. Theriogenology. 1988 Oct;30(4):649–657. [PubMed]
  • Thiry E, Saliki J, Pastoret PP, Lambert AF, Ligot J. Failure to demonstrate infectious bovine rhinotracheitis virus reactivation in parturient cows. Vet Rec. 1984 Sep 8;115(10):248–249. [PubMed]
  • Van Wuijckhuise L, Bosch J, Franken P, Frankena K, Elbers AR. Epidemiological characteristics of bovine herpesvirus 1 infections determined by bulk milk testing of all Dutch dairy herds. Vet Rec. 1998 Feb 21;142(8):181–184. [PubMed]
  • Pastoret PP, Thiry E. Diagnosis and prophylaxis of infectious bovine rhinotracheitis: the role of virus latency. Comp Immunol Microbiol Infect Dis. 1985;8(1):35–42. [PubMed]
  • Geng Y, Kashanchi F, Wood C. Activation of bovine immunodeficiency-like virus expression by bovine herpesvirus type 1. Virology. 1992 Apr;187(2):832–836. [PubMed]
  • Arthington JD, Corah LR, Blecha F. The effect of molybdenum-induced copper deficiency on acute-phase protein concentrations, superoxide dismutase activity, leukocyte numbers, and lymphocyte proliferation in beef heifers inoculated with bovine herpesvirus-1. J Anim Sci. 1996 Jan;74(1):211–217. [PubMed]
  • Hage JJ, Schukken YH, Barkema HW, Benedictus G, Rijsewijk FA, Wentink GH. Population dynamics of bovine herpesvirus 1 infection in a dairy herd. Vet Microbiol. 1996 Nov;53(1-2):169–180. [PubMed]
  • Tanyi J, Varga J. Guidelines for the eradication of infectious bovine rhinotracheitis in Hungary. Acta Vet Hung. 1992;40(3):165–169. [PubMed]
  • Homan EJ, Easterday BC. Isolation of bovine herpesvirus-1 from trigeminal ganglia of clinically normal cattle. Am J Vet Res. 1980 Aug;41(8):1212–1213. [PubMed]
  • Ackermann M, Peterhans E, Wyler R. DNA of bovine herpesvirus type 1 in the trigeminal ganglia of latently infected calves. Am J Vet Res. 1982 Jan;43(1):36–40. [PubMed]
  • Drew TW, Hewitt-Taylor C, Watson L, Edwards S. Effect of storage conditions and culture technique on the isolation of infectious bovine rhinotracheitis virus from bovine semen. Vet Rec. 1987 Dec 5;121(23):547–548. [PubMed]
  • Wentink GH, Rutten VP, van Exsel AC, de Jong WA, Vleugel H, Hensen EJ. Failure of an in vitro lymphoproliferative assay specific for bovine herpes virus type 1 to detect immunised or latently infected animals. Vet Q. 1990 Jul;12(3):175–182. [PubMed]
  • Florent G, de Marneffe C. Enzyme linked immunosorbent assay used to monitor serum antibodies to bovine respiratory disease viruses. Vet Microbiol. 1986 Apr;11(4):309–317. [PubMed]
  • Edwards S, Woods SB, Westcott DG, Emmerson M, Jones PC, Phillips AJ. An evaluation of five serological tests for the detection of antibody to bovine herpesvirus 1 in vaccinated and experimentally infected cattle. Res Vet Sci. 1986 Nov;41(3):378–382. [PubMed]
  • Kramps JA, Quak S, Weerdmeester K, van Oirschot JT. Comparative study on sixteen enzyme-linked immunosorbent assays for the detection of antibodies to bovine herpesvirus 1 in cattle. Vet Microbiol. 1993 May;35(1-2):11–21. [PubMed]
  • Deregt D, Cho HJ, Kozub GC. A comparative evaluation of two sensitive serum neutralization tests for bovine herpesvirus-1 antibodies. Can J Vet Res. 1993 Jan;57(1):56–59. [PMC free article] [PubMed]
  • Abdelmagid OY, Mansour MM, Minocha HC, van Drunen Littel-van den Hurk S. Evaluation of baculovirus-expressed bovine herpesvirus-1 (BHV-1) glycoproteins for detection and analysis of BHV-1-specific antibody responses. Vet Microbiol. 1998 Apr 15;61(4):249–259. [PubMed]
  • Kramps JA, Perrin B, Edwards S, van Oirschot JT. A European inter-laboratory trial to evaluate the reliability of serological diagnosis of bovine herpesvirus 1 infections. Vet Microbiol. 1996 Nov;53(1-2):153–161. [PubMed]
  • Andino RH, Torres HN, Polacino PS, Schudel A, Palma EL. Detection of bovine herpesvirus-1 nucleic acid sequences, using a dot-blot hybridization procedure. Am J Vet Res. 1987 Jun;48(6):984–987. [PubMed]
  • Vilcek S, Deliová I, Forgác O, Strojný L, Takácsová I, Harvan M, Benko G. Detection of bovine herpesvirus 1 with various types of DNA probes. Acta Vet Hung. 1993;41(1-2):179–190. [PubMed]
  • Van Engelenburg FA, Van Schie FW, Rijsewijk FA, Van Oirschot JT. Excretion of bovine herpesvirus 1 in semen is detected much longer by PCR than by virus isolation. J Clin Microbiol. 1995 Feb;33(2):308–312. [PMC free article] [PubMed]
  • Kibenge FS, Harris LM, McKenna PK, Wadowska D, Yason CV. Amplification of strains of bovine herpesvirus 1 by use of polymerase chain reaction with primers in the thymidine kinase region. Am J Vet Res. 1994 Sep;55(9):1206–1212. [PubMed]
  • Yason CV, Harris LM, McKenna PK, Wadowska D, Kibenge FS. Establishment of conditions for the detection of bovine herpesvirus-1 by polymerase chain reaction using primers in the thymidine kinase region. Can J Vet Res. 1995 Apr;59(2):94–101. [PMC free article] [PubMed]
  • Vilcek S, Nettleton PF, Herring JA, Herring AJ. Rapid detection of bovine herpesvirus 1 (BHV 1) using the polymerase chain reaction. Vet Microbiol. 1994 Sep;42(1):53–64. [PubMed]
  • van Engelenburg FA, Maes RK, van Oirschot JT, Rijsewijk FA. Development of a rapid and sensitive polymerase chain reaction assay for detection of bovine herpesvirus type 1 in bovine semen. J Clin Microbiol. 1993 Dec;31(12):3129–3135. [PMC free article] [PubMed]
  • Wiedmann M, Brandon R, Wagner P, Dubovi EJ, Batt CA. Detection of bovine herpesvirus-1 in bovine semen by a nested PCR assay. J Virol Methods. 1993 Sep;44(1):129–139. [PubMed]
  • Masri SA, Olson W, Nguyen PT, Prins S, Deregt D. Rapid detection of bovine herpesvirus 1 in the semen of infected bulls by a nested polymerase chain reaction assay. Can J Vet Res. 1996 Apr;60(2):100–107. [PMC free article] [PubMed]
  • Ashbaugh SE, Thompson KE, Belknap EB, Schultheiss PC, Chowdhury S, Collins JK. Specific detection of shedding and latency of bovine herpesvirus 1 and 5 using a nested polymerase chain reaction. J Vet Diagn Invest. 1997 Oct;9(4):387–394. [PubMed]
  • Lyaku JR, Vilcek S, Nettleton PF, Marsden HS. The distinction of serologically related ruminant alphaherpesviruses by the polymerase chain reaction (PCR) and restriction endonuclease analysis. Vet Microbiol. 1996 Jan;48(1-2):135–142. [PubMed]
  • Bruynzeel PL, Hamelink ML, Kok PT, van der Vet AP, Kreukniet J. Alpha 2-adrenergic receptors on intact human platelets of normal individuals and chronic obstructive lung disease patients. Eur J Respir Dis Suppl. 1984;135:139–142. [PubMed]
  • Rusvai M, Fodor L. Occurrence of some viruses and bacteria involved in respiratory diseases of ruminants in Hungary. Acta Vet Hung. 1998;46(4):405–414. [PubMed]
  • Schwyzer M, Ackermann M. Molecular virology of ruminant herpesviruses. Vet Microbiol. 1996 Nov;53(1-2):17–29. [PubMed]
  • Tikoo SK, Fitzpatrick DR, Babiuk LA, Zamb TJ. Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells. J Virol. 1990 Oct;64(10):5132–5142. [PMC free article] [PubMed]
  • Tikoo SK, Zamb TJ, Babiuk LA. Analysis of bovine herpesvirus 1 glycoprotein gIV truncations and deletions expressed by recombinant vaccinia viruses. J Virol. 1993 Apr;67(4):2103–2109. [PMC free article] [PubMed]
  • Chase CC, Lohff C, Letchworth GJ., 3rd Resistance and susceptibility of bovine cells expressing herpesviral glycoprotein D homologs to herpesviral infections. Virology. 1993 May;194(1):365–369. [PubMed]
  • Baranowski E, Keil G, Lyaku J, Rijsewijk FA, van Oirschot JT, Pastoret PP, Thiry E. Structural and functional analysis of bovine herpesvirus 1 minor glycoproteins. Vet Microbiol. 1996 Nov;53(1-2):91–101. [PubMed]
  • Liang X, Babiuk LA, Zamb TJ. An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing beta-galactosidase: evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization. Virology. 1992 Aug;189(2):629–639. [PubMed]
  • Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science. 1998 Jun 5;280(5369):1618–1620. [PubMed]
  • Montgomery RI, Warner MS, Lum BJ, Spear PG. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell. 1996 Nov 1;87(3):427–436. [PubMed]
  • Li Y, van Drunen Littel-van den Hurk S, Babiuk LA, Liang X. Characterization of cell-binding properties of bovine herpesvirus 1 glycoproteins B, C, and D: identification of a dual cell-binding function of gB. J Virol. 1995 Aug;69(8):4758–4768. [PMC free article] [PubMed]
  • Varthakavi V, Minocha HC. Identification of a 56 kDa putative bovine herpesvirus 1 cellular receptor by anti-idiotype antibodies. J Gen Virol. 1996 Aug;77(Pt 8):1875–1882. [PubMed]
  • Liang X, Pyne C, Li Y, Babiuk LA, Kowalski J. Delineation of the essential function of bovine herpesvirus 1 gD: an indication for the modulatory role of gD in virus entry. Virology. 1995 Mar 10;207(2):429–441. [PubMed]
  • Ludwig GV, Letchworth GJ., 3rd Temporal control of bovine herpesvirus 1 glycoprotein synthesis. J Virol. 1987 Oct;61(10):3292–3294. [PMC free article] [PubMed]
  • Misra V, Blumenthal RM, Babiuk LA. Proteins Specified by bovine herpesvirus 1 (infectious bovine rhinotracheitis virus). J Virol. 1981 Nov;40(2):367–378. [PMC free article] [PubMed]
  • Fitzpatrick DR, Babiuk LA, Zamb TJ. Nucleotide sequence of bovine herpesvirus type 1 glycoprotein gIII, a structural model for gIII as a new member of the immunoglobulin superfamily, and implications for the homologous glycoproteins of other herpesviruses. Virology. 1989 Nov;173(1):46–57. [PubMed]
  • Liang XP, Babiuk LA, Zamb TJ. Pseudorabies virus gIII and bovine herpesvirus 1 gIII share complementary functions. J Virol. 1991 Oct;65(10):5553–5557. [PMC free article] [PubMed]
  • Liang X, Tang M, Zamb TJ, Babiuk LA, Kowalski J, Tykocinski ML. Expression of glycoprotein gIII-human decay-accelerating factor chimera on the bovine herpesvirus 1 virion via a glycosyl phosphatidylinositol-based membrane anchor. J Virol. 1993 Aug;67(8):4896–4904. [PMC free article] [PubMed]
  • Liang X, Babiuk LA, Zamb TJ. Mapping of heparin-binding structures on bovine herpesvirus 1 and pseudorabies virus gIII glycoproteins. Virology. 1993 May;194(1):233–243. [PubMed]
  • Roizmann B, Desrosiers RC, Fleckenstein B, Lopez C, Minson AC, Studdert MJ. The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses. Arch Virol. 1992;123(3-4):425–449. [PubMed]
  • Whitbeck JC, Bello LJ, Lawrence WC. Comparison of the bovine herpesvirus 1 gI gene and the herpes simplex virus type 1 gB gene. J Virol. 1988 Sep;62(9):3319–3327. [PMC free article] [PubMed]
  • Misra V, Nelson R, Smith M. Sequence of a bovine herpesvirus type-1 glycoprotein gene that is homologous to the herpes simplex gene for the glycoprotein gB. Virology. 1988 Oct;166(2):542–549. [PubMed]
  • Rauh I, Weiland F, Fehler F, Keil GM, Mettenleiter TC. Pseudorabies virus mutants lacking the essential glycoprotein gII can be complemented by glycoprotein gI of bovine herpesvirus 1. J Virol. 1991 Feb;65(2):621–631. [PMC free article] [PubMed]
  • Kopp A, Mettenleiter TC. Stable rescue of a glycoprotein gII deletion mutant of pseudorabies virus by glycoprotein gI of bovine herpesvirus 1. J Virol. 1992 May;66(5):2754–2762. [PMC free article] [PubMed]
  • Fitzpatrick DR, Redmond MJ, Attah-Poku SK, van Drunen Littel-van den Hurk S, Babiuk LA, Zamb TJ. Mapping of 10 epitopes on bovine herpesvirus type 1 glycoproteins gI and gIII. Virology. 1990 May;176(1):145–157. [PubMed]
  • Vlcek C, Benes V, Lu Z, Kutish GF, Paces V, Rock D, Letchworth GJ, Schwyzer M. Nucleotide sequence analysis of a 30-kb region of the bovine herpesvirus 1 genome which exhibits a colinear gene arrangement with the UL21 to UL4 genes of herpes simplex virus. Virology. 1995 Jun 20;210(1):100–108. [PubMed]
  • Wirth UV, Gunkel K, Engels M, Schwyzer M. Spatial and temporal distribution of bovine herpesvirus 1 transcripts. J Virol. 1989 Nov;63(11):4882–4889. [PMC free article] [PubMed]
  • Seal BS, Whetstone CA, Zamb TJ, Bello LJ, Lawrence WC. Relationship of bovine herpesvirus 1 immediate-early, early, and late gene expression to host cellular gene transcription. Virology. 1992 May;188(1):152–159. [PubMed]
  • Fraefel C, Zeng J, Choffat Y, Engels M, Schwyzer M, Ackermann M. Identification and zinc dependence of the bovine herpesvirus 1 transactivator protein BICP0. J Virol. 1994 May;68(5):3154–3162. [PMC free article] [PubMed]
  • Singh M, Fraefel C, Bello LJ, Lawrence WC, Schwyzer M. Identification and characterization of BICP27, an early protein of bovine herpesvirus 1 which may stimulate mRNA 3' processing. J Gen Virol. 1996 Apr;77(Pt 4):615–625. [PubMed]
  • Schwyzer M, Vlcek C, Menekse O, Fraefel C, Paces V. Promoter, spliced leader, and coding sequence for BICP4, the largest of the immediate-early proteins of bovine herpesvirus 1. Virology. 1993 Nov;197(1):349–357. [PubMed]
  • Fraefel C, Ackermann M, Schwyzer M. Identification of the bovine herpesvirus 1 circ protein, a myristylated and virion-associated polypeptide which is not essential for virus replication in cell culture. J Virol. 1994 Dec;68(12):8082–8088. [PMC free article] [PubMed]
  • Hammerschmidt W, Ludwig H, Buhk HJ. Specificity of cleavage in replicative-form DNA of bovine herpesvirus 1. J Virol. 1988 Apr;62(4):1355–1363. [PMC free article] [PubMed]
  • Fraefel C, Wirth UV, Vogt B, Schwyzer M. Immediate-early transcription over covalently joined genome ends of bovine herpesvirus 1: the circ gene. J Virol. 1993 Mar;67(3):1328–1333. [PMC free article] [PubMed]
  • Misra V, Walker S, Hayes S, O'Hare P. The bovine herpesvirus alpha gene trans-inducing factor activates transcription by mechanisms different from those of its herpes simplex virus type 1 counterpart VP16. J Virol. 1995 Sep;69(9):5209–5216. [PMC free article] [PubMed]
  • Misra V, Bratanich AC, Carpenter D, O'Hare P. Protein and DNA elements involved in transactivation of the promoter of the bovine herpesvirus (BHV) 1 IE-1 transcription unit by the BHV alpha gene trans-inducing factor. J Virol. 1994 Aug;68(8):4898–4909. [PMC free article] [PubMed]
  • Huang CC, Herr W. Differential control of transcription by homologous homeodomain coregulators. Mol Cell Biol. 1996 Jun;16(6):2967–2976. [PMC free article] [PubMed]
  • Wirth UV, Vogt B, Schwyzer M. The three major immediate-early transcripts of bovine herpesvirus 1 arise from two divergent and spliced transcription units. J Virol. 1991 Jan;65(1):195–205. [PMC free article] [PubMed]
  • van Drunen Littel-van den Hurk S, Garzon S, van den Hurk JV, Babiuk LA, Tijssen P. The role of the major tegument protein VP8 of bovine herpesvirus-1 in infection and immunity. Virology. 1995 Jan 10;206(1):413–425. [PubMed]
  • Wirth UV, Fraefel C, Vogt B, Vlcek C, Paces V, Schwyzer M. Immediate-early RNA 2.9 and early RNA 2.6 of bovine herpesvirus 1 are 3' coterminal and encode a putative zinc finger transactivator protein. J Virol. 1992 May;66(5):2763–2772. [PMC free article] [PubMed]
  • Huemer HP, Larcher C, van Drunen Littel-van den Hurk S, Babiuk LA. Species selective interaction of Alphaherpesvirinae with the "unspecific" immune system of the host. Arch Virol. 1993;130(3-4):353–364. [PubMed]
  • Jacobs L. Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae. Arch Virol. 1994;137(3-4):209–228. [PubMed]
  • Hariharan MJ, Nataraj C, Srikumaran S. Down regulation of murine MHC class I expression by bovine herpesvirus 1. Viral Immunol. 1993 Winter;6(4):273–284. [PubMed]
  • Kutish G, Mainprize T, Rock D. Characterization of the latency-related transcriptionally active region of the bovine herpesvirus 1 genome. J Virol. 1990 Dec;64(12):5730–5737. [PMC free article] [PubMed]
  • Schang LM, Hossain A, Jones C. The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression. J Virol. 1996 Jun;70(6):3807–3814. [PMC free article] [PubMed]
  • Jiang Y, Hossain A, Winkler MT, Holt T, Doster A, Jones C. A protein encoded by the latency-related gene of bovine herpesvirus 1 is expressed in trigeminal ganglionic neurons of latently infected cattle and interacts with cyclin-dependent kinase 2 during productive infection. J Virol. 1998 Oct;72(10):8133–8142. [PMC free article] [PubMed]
  • Jones C, Delhon G, Bratanich A, Kutish G, Rock D. Analysis of the transcriptional promoter which regulates the latency-related transcript of bovine herpesvirus 1. J Virol. 1990 Mar;64(3):1164–1170. [PMC free article] [PubMed]
  • Bratanich AC, Jones CJ. Localization of cis-acting sequences in the latency-related promoter of bovine herpesvirus 1 which are regulated by neuronal cell type factors and immediate-early genes. J Virol. 1992 Oct;66(10):6099–6106. [PMC free article] [PubMed]
  • Devireddy LR, Jones C. Alternative splicing of the latency-related transcript of bovine herpesvirus 1 yields RNAs containing unique open reading frames. J Virol. 1998 Sep;72(9):7294–7301. [PMC free article] [PubMed]
  • Schang LM, Jones C. Analysis of bovine herpesvirus 1 transcripts during a primary infection of trigeminal ganglia of cattle. J Virol. 1997 Sep;71(9):6786–6795. [PMC free article] [PubMed]
  • Whetstone CA, Miller JM, Seal BS, Bello LJ, Lawrence WC. Latency and reactivation of a thymidine kinase-negative bovine herpesvirus 1 deletion mutant. Arch Virol. 1992;122(1-2):207–214. [PubMed]
  • Rock D, Lokensgard J, Lewis T, Kutish G. Characterization of dexamethasone-induced reactivation of latent bovine herpesvirus 1. J Virol. 1992 Apr;66(4):2484–2490. [PMC free article] [PubMed]
  • van Engelenburg FA, Kaashoek MJ, van Oirschot JT, Rijsewijk FA. A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period. J Gen Virol. 1995 Sep;76(Pt 9):2387–2392. [PubMed]
  • Bielefeldt Ohmann H, Babiuk LA, Harland R. Cytokine synergy with viral cytopathic effects and bacterial products during the pathogenesis of respiratory tract infection. Clin Immunol Immunopathol. 1991 Aug;60(2):153–170. [PubMed]
  • Campos M, Ohmann HB, Hutchings D, Rapin N, Babiuk LA, Lawman MJ. Role of interferon-gamma in inducing cytotoxicity of peripheral blood mononuclear leukocytes to bovine herpesvirus type 1 (BHV-1)-infected cells. Cell Immunol. 1989 Apr 15;120(1):259–269. [PubMed]
  • Hutchings DL, van Drunen Littel-van den Hurk S, Babiuk LA. Lymphocyte proliferative responses to separated bovine herpesvirus 1 proteins in immune cattle. J Virol. 1990 Oct;64(10):5114–5122. [PMC free article] [PubMed]
  • Babiuk LA, van Drunen Littel-van den Hurk S, Tikoo SK. Immunology of bovine herpesvirus 1 infection. Vet Microbiol. 1996 Nov;53(1-2):31–42. [PubMed]
  • Choi SH, Splitter GA. Induction of MHC-unrestricted cytolytic CD4+ T cells against virally infected target cells by cross-linking CD4 molecules. J Immunol. 1994 Nov 1;153(9):3874–3881. [PubMed]
  • Denis M, Slaoui M, Keil G, Babiuk LA, Ernst E, Pastoret PP, Thiry E. Identification of different target glycoproteins for bovine herpes virus type 1-specific cytotoxic T lymphocytes depending on the method of in vitro stimulation. Immunology. 1993 Jan;78(1):7–13. [PubMed]
  • Wang C, Splitter GA. CD4(+) cytotoxic T-lymphocyte activity against macrophages pulsed with bovine herpesvirus 1 polypeptides. J Virol. 1998 Sep;72(9):7040–7047. [PMC free article] [PubMed]
  • Hanon E, Meyer G, Vanderplasschen A, Dessy-Doizé C, Thiry E, Pastoret PP. Attachment but not penetration of bovine herpesvirus 1 is necessary to induce apoptosis in target cells. J Virol. 1998 Sep;72(9):7638–7641. [PMC free article] [PubMed]
  • Ryan AM, Womack JE. A molecular genetic approach to improved animal health. The effect of interferon genotype on the severity of experimental bovine herpesvirus-1 infection. Vet Clin North Am Food Anim Pract. 1997 Nov;13(3):401–409. [PubMed]
  • Yu Z, Manickan E, Rouse BT. Role of interferon-gamma in immunity to herpes simplex virus. J Leukoc Biol. 1996 Oct;60(4):528–532. [PubMed]
  • Milligan GN, Bernstein DI. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology. 1997 Mar 3;229(1):259–268. [PubMed]
  • Otsuka H, Qavi H, Kit S. Inhibition by interferon of biochemical transformation induced by cloned herpesvirus thymidine kinase genes. Antiviral Res. 1982 Oct;2(5):301–311. [PubMed]
  • Hughes HP, Campos M, Godson DL, Van Drunen Littel-Van den Hurk S, McDougall L, Rapin N, Zamb T, Babiuk LA. Immunopotentiation of bovine herpes virus subunit vaccination by interleukin-2. Immunology. 1991 Nov;74(3):461–466. [PubMed]
  • Reddy PG, Blecha F, Minocha HC, Anderson GA, Morrill JL, Fedorka-Cray PJ, Baker PE. Bovine recombinant interleukin-2 augments immunity and resistance to bovine herpesvirus infection. Vet Immunol Immunopathol. 1989 Nov 30;23(1-2):61–74. [PubMed]
  • Hughes HP, Campos M, van Drunen Littel-van den Hurk S, Zamb T, Sordillo LM, Godson D, Babiuk LA. Multiple administration with interleukin-2 potentiates antigen-specific responses to subunit vaccination with bovine herpesvirus-1 glycoprotein IV. Vaccine. 1992;10(4):226–230. [PubMed]
  • Reddy DN, Reddy PG, Minocha HC, Fenwick BW, Baker PE, Davis WC, Blecha F. Adjuvanticity of recombinant bovine interleukin-1 beta: influence on immunity, infection, and latency in a bovine herpesvirus-1 infection. Lymphokine Res. 1990 Fall;9(3):295–307. [PubMed]
  • Reddy DN, Reddy PG, Xue W, Minocha HC, Daley MJ, Blecha F. Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1 beta and interleukin-2. Vet Immunol Immunopathol. 1993 Jun;37(1):25–38. [PubMed]
  • Baca-Estrada ME, Godson DL, Hughes HP, Van Donkersgoed J, Van Kessel A, Harland R, Shuster DE, Daley M, Babiuk LA. Effect of recombinant bovine interleukin-1 beta on viral/bacterial pneumonia in cattle. J Interferon Cytokine Res. 1995 May;15(5):431–439. [PubMed]
  • Leib DA, Olivo PD. Gene delivery to neurons: is herpes simplex virus the right tool for the job? Bioessays. 1993 Aug;15(8):547–554. [PubMed]
  • Glorioso JC, DeLuca NA, Fink DJ. Development and application of herpes simplex virus vectors for human gene therapy. Annu Rev Microbiol. 1995;49:675–710. [PubMed]
  • Bello LJ, Whitbeck JC, Lawrence WC. Bovine herpesvirus 1 as a live virus vector for expression of foreign genes. Virology. 1992 Oct;190(2):666–673. [PubMed]
  • Kit M, Kit S, Little SP, Di Marchi RD, Gale C. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes. Vaccine. 1991 Aug;9(8):564–572. [PubMed]
  • Kit S, Otsuka H, Kit M. Expression of porcine pseudorabies virus genes by a bovine herpesvirus-1 (infectious bovine rhinotracheitis virus) vector. Arch Virol. 1992;124(1-2):1–20. [PubMed]
  • Otsuka H, Xuan X. Construction of bovine herpesvirus-1 (BHV-1) recombinants which express pseudorabies virus (PRV) glycoproteins gB, gC, gD, and gE. Arch Virol. 1996;141(1):57–71. [PubMed]
  • Ackermann M, Bélak S, Bitsch V, Edwards S, Moussa A, Rockborn G, Thiry E. Round table on infectious bovine rhinotracheitis/infectious pustular vulvovaginitis virus infection diagnosis and control. Vet Microbiol. 1990 Jun;23(1-4):361–363. [PubMed]
  • Lemaire M, Schynts F, Meyer G, Thiry E. Antibody response to glycoprotein E after bovine herpesvirus type 1 infection in passively immunised, glycoprotein E-negative calves. Vet Rec. 1999 Feb 13;144(7):172–176. [PubMed]
  • Lemaire M, Meyer G, Ernst E, Vanherreweghe V, Limbourg B, Pastoret PP, Thiry E. Latent bovine herpesvirus 1 infection in calves protected by colostral immunity. Vet Rec. 1995 Jul 15;137(3):70–71. [PubMed]
  • van Oirschot JT, Kaashoek MJ, Rijsewijk FA. Advances in the development and evaluation of bovine herpesvirus 1 vaccines. Vet Microbiol. 1996 Nov;53(1-2):43–54. [PubMed]
  • MADIN SH, MCKERCHER DG, YORK CJ. Isolation of the infectious bovine rhinotracheitis virus. Science. 1956 Oct 19;124(3225):721–722. [PubMed]
  • Straub OC, Mawhinney IC. Vaccination to protect calves against infectious bovine rhinotracheitis. Vet Rec. 1988 Apr 23;122(17):407–411. [PubMed]
  • Zygraich N, Lobmann M, Vascoboinic E, Berge E, Huygelen C. In vivo and in vitro properties of a temperature sensitive mutant of infectious bovine Rhinotracheitis virus. Res Vet Sci. 1974 May;16(3):328–335. [PubMed]
  • Whetstone CA, Wheeler JG, Reed DE. Investigation of possible vaccine-induced epizootics of infectious bovine rhinotracheitis, using restriction endonuclease analysis of viral DNA. Am J Vet Res. 1986 Aug;47(8):1789–1795. [PubMed]
  • Whetstone C, Miller J, Bortner D, Van der Maaten M. Changes in the restriction endonuclease patterns of four modified-live infectious bovine rhinotracheitis virus (IBRV) vaccines after one passage in host animal. Vaccine. 1989 Dec;7(6):527–532. [PubMed]
  • Duque H, Marshall RL, Israel BA, Letchworth GJ. Effects of formalin inactivation on bovine herpes virus-1 glycoproteins and antibody response elicited by formalin-inactivated vaccines in rabbits. Vaccine. 1989 Dec;7(6):513–520. [PubMed]
  • Frerichs GN, Woods SB, Lucas MH, Sands JJ. Safety and efficacy of live and inactivated infectious bovine rhinotracheitis vaccines. Vet Rec. 1982 Aug 7;111(6):116–122. [PubMed]
  • Bryan LA, Fenton RA, Misra V, Haines DM. Fatal, generalized bovine herpesvirus type-1 infection associated with a modified-live infectious bovine rhinotracheitis parainfluenza-3 vaccine administered to neonatal calves. Can Vet J. 1994 Apr;35(4):223–228. [PMC free article] [PubMed]
  • Baker JC, Rust SR, Walker RD. Transmission of a vaccinal strain of infectious bovine rhinotracheitis virus from intranasally vaccinated steers commingled with nonvaccinated steers. Am J Vet Res. 1989 Jun;50(6):814–816. [PubMed]
  • Pastoret PP, Babiuk LA, Misra V, Griebel P. Reactivation of temperature-sensitive and non-temperature-sensitive infectious bovine rhinotracheitis vaccine virus with dexamethasone. Infect Immun. 1980 Aug;29(2):483–488. [PMC free article] [PubMed]
  • George LW, Ardans A, Mihalyi J, Guerra MR. Enhancement of infectious bovine keratoconjunctivitis by modified-live infectious bovine rhinotracheitis virus vaccine. Am J Vet Res. 1988 Nov;49(11):1800–1806. [PubMed]
  • Kelling CL, Schipper IA, Strum GE, Carlson RB, Tilton JE. Infectious bovine rhinotracheitis (IBR) abortion observations on incidence in vaccinated and non-vaccinated and exposed cattle. Cornell Vet. 1973 Jul;63(3):383–389. [PubMed]
  • Van der Maaten MJ, Miller JM, Whetstone CA. Ovarian lesions induced in heifers by intravenous inoculation with modified-live infectious bovine rhinotracheitis virus on the day after breeding. Am J Vet Res. 1985 Sep;46(9):1996–1999. [PubMed]
  • Smith PC, Nusbaum KE, Kwapien RP, Stringfellow DA, Driggers K. Necrotic oophoritis in heifers vaccinated intravenously with infectious bovine rhinotracheitis virus vaccine during estrus. Am J Vet Res. 1990 Jul;51(7):969–972. [PubMed]
  • Harasawa R. Adventitious pestivirus RNA in live virus vaccines against bovine and swine diseases. Vaccine. 1995 Jan;13(1):100–103. [PubMed]
  • Babiuk LA, L'Italien J, van Drunen Littel-van den Hurk S, Zamb T, Lawman JP, Hughes G, Gifford GA. Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins. Virology. 1987 Jul;159(1):57–66. [PubMed]
  • van Drunen Littel-van den Hurk S, van den Hurk JV, Gilchrist JE, Misra V, Babiuk LA. Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology. 1984 Jun;135(2):466–479. [PubMed]
  • Collins JK, Butcher AC, Riegel CA. Immune response to bovine herpes herpesvirus type 1 infections: virus-specific antibodies in sera from infected animals. J Clin Microbiol. 1985 Apr;21(4):546–552. [PMC free article] [PubMed]
  • Israel BA, Marshall RL, Letchworth GJ., 3rd Epitope specificity and protective efficacy of the bovine immune response to bovine herpesvirus-1 glycoprotein vaccines. Vaccine. 1988 Aug;6(4):349–356. [PubMed]
  • Kaashoek MJ, Moerman A, Madić J, Weerdmeester K, Maris-Veldhuis M, Rijsewijk FA, van Oirschot JT. An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine. 1995 Mar;13(4):342–346. [PubMed]
  • Zhu X, Letchworth GJ., 3rd Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle. Vaccine. 1996 Jan;14(1):61–69. [PubMed]
  • Babiuk LA, van Drunen Littel-van den Hurk S, Tikoo SK, Lewis PJ, Liang X. Novel viral vaccines for livestock. Vet Immunol Immunopathol. 1996 Nov;54(1-4):355–363. [PubMed]
  • Fitzpatrick DR, Zamb T, Parker MD, van Drunen Littel-van den Hurk S, Babiuk LA, Lawman MJ. Expression of bovine herpesvirus 1 glycoproteins gI and gIII in transfected murine cells. J Virol. 1988 Nov;62(11):4239–4248. [PMC free article] [PubMed]
  • van Drunen Littel-van den Hurk S, Zamb T, Babiuk LA. Synthesis, cellular location, and immunogenicity of bovine herpesvirus 1 glycoproteins gI and gIII expressed by recombinant vaccinia virus. J Virol. 1989 May;63(5):2159–2168. [PMC free article] [PubMed]
  • Leary TP, Gao Y, Splitter GA. Constitutively expressing cell lines that secrete a truncated bovine herpes virus-1 glycoprotein (gpI) stimulate T-lymphocyte responsiveness. Immunology. 1992 Jul;76(3):367–372. [PubMed]
  • van Drunen Littel-van den Hurk S, Parker MD, Massie B, van den Hurk JV, Harland R, Babiuk LA, Zamb TJ. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine. 1993;11(1):25–35. [PubMed]
  • van Drunen Littel-van den Hurk S, Parker MD, Fitzpatrick DR, Zamb TJ, van den Hurk JV, Campos M, Harland R, Babiuk LA. Expression of bovine herpesvirus 1 glycoprotein gIV by recombinant baculovirus and analysis of its immunogenic properties. J Virol. 1991 Jan;65(1):263–271. [PMC free article] [PubMed]
  • van Drunen Littel-van den Hurk S, Van Donkersgoed J, Kowalski J, van den Hurk JV, Harland R, Babiuk LA, Zamb TJ. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine. 1994 Nov;12(14):1295–1302. [PubMed]
  • Merza M, Tibor S, Kucsera L, Bognar G, Morein B. ISCOM of BHV-1 envelope glycoproteins protected calves against both disease and infection. Zentralbl Veterinarmed B. 1991 Jun;38(4):306–314. [PubMed]
  • Garcia-Valcarcel M, Fowler WJ, Harper DR, Jeffries DJ, Layton GT. Cloning, expression, and immunogenicity of the assembly protein of varicella-zoster virus and detection of the products of open reading frame 33. J Med Virol. 1997 Dec;53(4):332–339. [PubMed]
  • Trudel M, Nadon F, Seguin C, Boulay G, Lussier G. Vaccination of rabbits with a bovine herpesvirus type 1 subunit vaccine: adjuvant effect of ISCOMs. Vaccine. 1987 Sep;5(3):239–243. [PubMed]
  • Moser CA, Speaker TJ, Offit PA. Effect of microencapsulation on immunogenicity of a bovine herpes virus glycoprotein and inactivated influenza virus in mice. Vaccine. 1997 Nov;15(16):1767–1772. [PubMed]
  • Young PL, Smith GA. Genetically altered herpesviruses as vaccines. Vet Microbiol. 1995 Sep;46(1-3):175–179. [PubMed]
  • Kit S, Qavi H, Gaines JD, Billingsley P, McConnell S. Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves. Arch Virol. 1985;86(1-2):63–83. [PubMed]
  • Smith GA, Young PL, Rodwell BJ, Kelly MA, Storie GJ, Farrah CA, Mattick JS. Development and trial of a bovine herpesvirus 1-thymidine kinase deletion virus as a vaccine. Aust Vet J. 1994 Mar;71(3):65–70. [PubMed]
  • Liu KY, Manning JS. Identification of the thymidine kinase gene of infectious bovine rhinotracheitis virus and its function in Escherichia coli hosts. Gene. 1986;44(2-3):279–285. [PubMed]
  • Bello LJ, Whitbeck JC, Lawrence WC. Map location of the thymidine kinase gene of bovine herpesvirus 1. J Virol. 1987 Dec;61(12):4023–4025. [PMC free article] [PubMed]
  • Kaashoek MJ, Moerman A, Madić J, Rijsewijk FA, Quak J, Gielkens AL, van Oirschot JT. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine. 1994 Apr;12(5):439–444. [PubMed]
  • van Oirschot JT. Vaccination in food animal populations. Vaccine. 1994 Apr;12(5):415–418. [PubMed]
  • Kaashoek MJ, van Engelenburg FA, Moerman A, Gielkens AL, Rijsewijk FA, van Oirschot JT. Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants. Vet Microbiol. 1996 Jan;48(1-2):143–153. [PubMed]
  • Flores EF, Osorio FA, Zanella EL, Kit S, Kit M. Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serologic differentiation of vaccinated from naturally infected animals. J Vet Diagn Invest. 1993 Oct;5(4):534–540. [PubMed]
  • Bosch JC, Frankena K, van Oirschot JT. Effect on milk production of vaccination with a bovine herpesvirus 1 gene-deleted vaccine. Vet Rec. 1997 Feb 22;140(8):196–199. [PubMed]
  • Strube W, Auer S, Block W, Heinen E, Kretzdorn D, Rodenbach C, Schmeer N. A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs. Vet Microbiol. 1996 Nov;53(1-2):181–189. [PubMed]
  • Chowdhury SI. Construction and characterization of an attenuated bovine herpesvirus type 1 (BHV-1) recombinant virus. Vet Microbiol. 1996 Sep;52(1-2):13–23. [PubMed]
  • Kühnle G, Collins RA, Scott JE, Keil GM. Bovine interleukins 2 and 4 expressed in recombinant bovine herpesvirus 1 are biologically active secreted glycoproteins. J Gen Virol. 1996 Sep;77(Pt 9):2231–2240. [PubMed]
  • Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood. 1991 Apr 15;77(8):1627–1652. [PubMed]
  • Raggo C, Fitzpatrick DR, Babiuk LA, Liang X. Expression of bovine interleukin-1 beta in a bovine herpesvirus-1 vector: in vitro analysis. Virology. 1996 Jul 1;221(1):78–86. [PubMed]
  • Cox GJ, Zamb TJ, Babiuk LA. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol. 1993 Sep;67(9):5664–5667. [PMC free article] [PubMed]
  • Terpstra C, Kroese AH. Potency control of modified live viral vaccines for veterinary use. Vaccine. 1996 Jan;14(1):13–18. [PubMed]
  • Strube W, Abar B, Bergle RD, Block W, Heinen E, Kretzdorn D, Rodenbach C, Schmeer N. Safety aspects in the development of an infectious bovine rhinotracheitis marker vaccine. Dev Biol Stand. 1995;84:75–81. [PubMed]
  • Mettenleiter TC. Conclusions from the symposium. Vet Microbiol. 1996 Nov;53(1-2):207–211. [PubMed]
  • van Drunen Littel-van den Hurk S, Khattar S, Tikoo SK, Babiuk LA, Baranowski E, Plainchamp D, Thiry E. Glycoprotein H (gII/gp108) and glycoprotein L form a functional complex which plays a role in penetration, but not in attachment, of bovine herpesvirus 1. J Gen Virol. 1996 Jul;77(Pt 7):1515–1520. [PubMed]
  • Baranowski E, Dubuisson J, van Drunen Little-van den Hurk S, Babiuk AL, Michel A, Pastoret PP, Thiry E. Synthesis and processing of bovine herpesvirus-1 glycoprotein H. Virology. 1995 Jan 10;206(1):651–654. [PubMed]
  • Chowdhury SI. Fine mapping of bovine herpesvirus 1 (BHV-1) glycoprotein C neutralizing epitopes by type-specific monoclonal antibodies and synthetic peptides. Vet Microbiol. 1997 Nov;58(2-4):309–314. [PubMed]
  • Keil GM, Engelhardt T, Karger A, Enz M. Bovine herpesvirus 1 U(s) open reading frame 4 encodes a glycoproteoglycan. J Virol. 1996 May;70(5):3032–3038. [PMC free article] [PubMed]
  • Kühnle G, Heinze A, Schmitt J, Giesow K, Taylor G, Morrison I, Rijsewijk FA, van Oirschot JT, Keil GM. The class II membrane glycoprotein G of bovine respiratory syncytial virus, expressed from a synthetic open reading frame, is incorporated into virions of recombinant bovine herpesvirus 1. J Virol. 1998 May;72(5):3804–3811. [PMC free article] [PubMed]
  • Khadr A, Tikoo SK, Babiuk LA, van Drunen Littel-van den Hurk S. Sequence and expression of a bovine herpesvirus-1 gene homologous to the glycoprotein K-encoding gene of herpes simplex virus-1. Gene. 1996 Feb 12;168(2):189–193. [PubMed]
  • Wu SX, Zhu XP, Letchworth GJ. Bovine herpesvirus 1 glycoprotein M forms a disulfide-linked heterodimer with the U(L)49.5 protein. J Virol. 1998 Apr;72(4):3029–3036. [PMC free article] [PubMed]
  • Khattar SK, van Drunen Littel-van den Harke S, Attah-Poku SK, Babiuk LA, Tikoo SK. Identification and characterization of a bovine herpesvirus-1 (BHV-1) glycoprotein gL which is required for proper antigenicity, processing, and transport of BHV-1 glycoprotein gH. Virology. 1996 May 1;219(1):66–76. [PubMed]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ